Moreover, the emergence of personalized medicine is influencing API development. With advancements in genomics and biotechnology, pharmaceutical companies are increasingly focusing on tailored therapies. This trend demands APIs that can be adapted to meet individual patient profiles, leading to more effective treatment outcomes. Consequently, the exploration of biopharmaceuticals—APIs derived from biological sources—has expanded significantly.
L-ornithine and L-aspartate are naturally occurring amino acids that play significant roles in various physiological processes in the human body. Their unique properties and functions have garnered attention in the field of nutrition and medicine, particularly concerning liver health, metabolic disorders, and athletic performance.